Navigation Links
Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth
Date:10/5/2010

c and management teams and provide advice and guidance in refining our science to enable us to capitalize on our Company's promising future.  For Generex Oncology, we have brought in Dr. Craig Eagle, the head of the oncology therapeutic area of the global medical group for Pfizer, Inc., as an advisor to help us navigate through the regulatory approval process for AE37 as well to help us in our strategic partnership efforts within the pharmaceutical community.  We have also retained the consulting services of Dr. George M. Peoples, presently the Chief of Surgical Oncology at Brooke Army Medical Center in Houston, TX, a Professor of Surgery and the Director & Principal Investigator of the Cancer Vaccine Development Program at Uniformed Services University of the Health Sciences in Bethesda, MD, and the Deputy Director of the United States Military Cancer Institute (www.usmci.org).  Dr. Peoples is providing advice and assistance to us with respect to the design and implementation of a Phase III trial of the AE37 vaccine in patients with breast cancer, and acts as a liaison with the FDA regarding the clinical and regulatory development of the vaccine.  We also have engaged the services of a world-renowned independent firm used by many major pharmaceutical companies for intellectual property appraisals, to provide an appraisal of our vaccine technology platform.

As I navigate our Company through this transitional period in management, I feel it is important to communicate to our shareholders that management is committed to bringing our rich intellectual property resources to commercial fruition.  We continue to work closely with our business development consultants, including Seahawk Capital, which was instrumental in helping us regain our financial footing in 2009.  We intend to seek out unique opportunities to generate meaningful near-term revenue streams. We are confident that, together with
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... affects persons of all ages, but most commonly ... condition characterized by narrowing of the airways, leading ... the lungs come into contact with endogenous and ... of events, such as swelling of the airways, ...
(Date:9/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Valeant Pharmaceuticals International, will redeem all of the outstanding ... Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 (the " ... an irrevocable notice of redemption for the Notes. ... irrevocable notice of redemption with respect to the remaining ...
(Date:9/15/2014)... Sept. 15, 2014  Decision Resources Group,s ... 2014, finds that online information and other ... to differentiate their offering and support physicians. ... purchasing decisions rely on websites, mobile apps ... devices—and these physicians are looking to manufacturers ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3
... , LAWRENCEVILLE, N.J. , Feb. 16 ... announced today that Wayne S. Mulcahy , Ph.D., ... A wholly owned subsidiary of Princeton Pharma Holdings LLC, ... unique products in ophthalmology and orphan diseases. , ...
... , GLEN BURNIE, Md. , Feb. ... delivery provider of prescription medications and veterinary therapeutic and ... Health, opening up the full suite of Pfizer products ... Health is the world,s leader in the discovery, development ...
Cached Medicine Technology:Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2VetCentric Announces Partnership With Pfizer Animal Health 2
(Date:9/15/2014)... “Canada Gynecological Devices Market Outlook ... Canada Gynecological Devices market. The report provides value, ... and average prices (in US dollars) within market ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ... Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), ...
(Date:9/15/2014)... In order to provide predictability and safety, ... to quantify, define and model medical practice. Defined as ... of medical care. , The Journal of BioAcoustic Biology ... the non-profit Institute of BioAcoustic Biology, located in Albany, ... be much more than a measurement tool; math, as ...
(Date:9/15/2014)... Florida is now one of several states holding “no ... test could be forced to undergo a mandatory blood test. ... more people from drinking and driving. , Federal government ... breathalyzer refusal. The new law is aimed to lower this ... , the new Florida law requires people to take a ...
(Date:9/15/2014)... Dennis Thompson HealthDay Reporter ... The severe respiratory virus believed to have sickened hundreds ... now spread to the Northeast, health officials report. ... Friday more than a dozen cases of infection with ... with asthma. And on Saturday, the Connecticut Department ...
(Date:9/15/2014)... 15, 2014 (HealthDay News) -- Births of multiple babies ... death than singleton births, researchers report. The researchers ... vitro fertilization (IVF) could ease some of that burden. ... increased in tandem with births to older mothers and ... the University of New South Wales, Australia. Their ...
Breaking Medicine News(10 mins):Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:New DUI Law Makes Blood Tests Mandatory 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3
... California will simultaneously open their doors,Wednesday to Trick or ... SAN DIEGO, Oct. 30 It,s not every ... don,t often,see miniature witches and 3-foot-tall bumblebees, and little ... But at more,than 150 nursing homes in California this ...
... Va.SNM, the worlds largest society for molecular imaging and ... in Tuesdays Roll Call urging Congress to fund basic ... future discoveries. Support DOE funding for nuclear medicine research, ... provides news of legislative and political interest to Capitol ...
... good responses in almost half of patients, study found , ... axitinib shows promise for treating people with what,s known as ... typically have a poor response to drug treatment. , Axitinib ... endothelial growth factor receptors 1, 2 and 3. , ...
... Ohio, Oct. 30 STERIS Corporation,(NYSE: STE ) ... ended September 30, 2007. Fiscal 2008 second quarter revenues,increased ... the second,quarter of fiscal 2007, primarily driven by growth ... quarter net income was $16.0 million, or $0.25 per,diluted ...
... Inc.,(Pink Sheets: HRAL) announced that it has received additional ... International, Inc.,(NYSE: WMT ), to open their ninth ... Wal-Mart Store #3195 located at 1070 Major,Mackenzie Drive in ... #7 Unit Y006A in Markham will both officially open ...
... Oct. 30 Anthera Pharmaceuticals,Inc., a privately held ... diseases, today announced,that Donald J. Santel has been ... experience in transforming early biotech startups into,commercial stage ... our pipeline,and move A-002 into large scale Phase ...
Cached Medicine News:Health News:Halloween Events Bring Young and Old Together for a Ghoulish Good Time 2Health News:SNM ad urges congress to fund nuclear medicine research 2Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
... to bring efficiency and quality to routine ... superior technology of fluorescent flow cytometry with ... sampling or batch processing are easily accommodated ... in high volume laboratories. Fluorescent flow ...
... The iQ200 System incorporates the ... and the AUTION MAX™ AX-4280 Automated ... a fully integrated chemical and microscopic ... (APR™), a well trained neural network, ...
... UF-100 is designed to bring efficiency and ... It combines the superior technology of fluorescent ... analysis. Continuous sampling or batch processing ... streamlining sample processing in high volume laboratories. ...
Medicine Products: